Nanotechnology in Cancer 2017
DOI: 10.1016/b978-0-323-39080-4.00002-1
|View full text |Cite
|
Sign up to set email alerts
|

Silk fibroin nanoparticles and cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…In the past decade silk fibroin nanoparticles (SFN) have received considerable attention as a drug delivery system (DDS) due their high binding capacity for various drugs, and interesting properties related to controlled drug release, good biocompatibility, and the ability to degrade into harmless products in biological media. , To date, several preparation methods for the preparation of particles from natural silk fibroins (from silkworms, bees, or spiders, among others), ,,, or recombinant silks have been described. Apart from the development of the preparation methods, multiple combinations of drugs and SFNs employing different adsorption or encapsulation techniques have been also reported. Although many past in vitro and in vivo studies evaluating the biocompatibility and biodegradability of SF have been developed involving bulk implants, few examples of the evaluation of the inflammatory effects or endocytic uptake of SF particles in relation to their size are available. Thus, there is still an acute lack of information about their distribution in vivo after tissue injection or intravenous administration.…”
Section: Introductionmentioning
confidence: 99%
“…In the past decade silk fibroin nanoparticles (SFN) have received considerable attention as a drug delivery system (DDS) due their high binding capacity for various drugs, and interesting properties related to controlled drug release, good biocompatibility, and the ability to degrade into harmless products in biological media. , To date, several preparation methods for the preparation of particles from natural silk fibroins (from silkworms, bees, or spiders, among others), ,,, or recombinant silks have been described. Apart from the development of the preparation methods, multiple combinations of drugs and SFNs employing different adsorption or encapsulation techniques have been also reported. Although many past in vitro and in vivo studies evaluating the biocompatibility and biodegradability of SF have been developed involving bulk implants, few examples of the evaluation of the inflammatory effects or endocytic uptake of SF particles in relation to their size are available. Thus, there is still an acute lack of information about their distribution in vivo after tissue injection or intravenous administration.…”
Section: Introductionmentioning
confidence: 99%
“…Hepatocellular carcinoma [187] SF-Thelebolan matrix Soft tissue carcinoma [188] Doxorubicin loaded SF nanoparticles Brain cancer [189] SF-Sodium alginate nanocarriers Colorectal cancer [190] SF-based metastasis model Breast cancer [191] Triptolide-Celastrol-loaded SF nanoparticles Pancreatic cancer [192] Alpha-mangostin loaded SF nanoparticles Colon cancer; Breast cancer [193] SF rods Breast cancer [194] Quercetin loaded SF nanoparticles Breast cancer; Lung metastasis [195] Biliverdin-SF hydrogel Glioma [196] Floxuridine-loaded SF nanospheres Digestive tract cancer; Lung cancer [197] Curcumin-loaded SF nanoparticles Breast cancer [198] Insects 2022, 13, x 18 of 26…”
Section: Sf Hydrogelsmentioning
confidence: 99%
“…To assess the biocompatibility of the 3B/GE/PCL sample, an MTT assay was performed. MTT assays provide a quantitative assessment of the cellular response to the surface of coated substrates [55][56][57]. The results of cell viability illustrated in Figure 7 were determined by the cell counting method [58].…”
Section: Mtt Analysismentioning
confidence: 99%